Display options
Cite
Li J, Gao X, Luo T, et al. Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis. Emerg Microbes Infect. 2014;3(3):e19doi: 10.1038/emi.2014.21.
Li, J., Gao, X., Luo, T., Wu, J., Sun, G., Liu, Q., Jiang, Y., Zhang, Y., Mei, J., & Gao, Q. (2014). Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis. Emerging microbes & infections, 3(3), e19. https://doi.org/10.1038/emi.2014.21
Li, Jing, et al. "Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis." Emerging microbes & infections vol. 3,3 (2014): e19. doi: https://doi.org/10.1038/emi.2014.21
Li J, Gao X, Luo T, Wu J, Sun G, Liu Q, Jiang Y, Zhang Y, Mei J, Gao Q. Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis. Emerg Microbes Infect. 2014 Mar;3(3):e19. doi: 10.1038/emi.2014.21. Epub 2014 Mar 12. PMID: 26038513; PMCID: PMC3974338.
Copy Download .nbib Format: NLM
Share it on

Emerg Microbes Infect. 2014 Mar;3(3):e19. doi: 10.1038/emi.2014.21. Epub 2014 Mar 12.

Association of gyrA/B mutations and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis.

Emerging microbes & infections

Jing Li, Xu Gao, Tao Luo, Jie Wu, Gang Sun, Qingyun Liu, Yuan Jiang, Yangyi Zhang, Jian Mei, Qian Gao

Affiliations

  1. The Department of TB Control, Shanghai Municipal Centers for Disease Control and Prevention , Shanghai 200336, China.
  2. Key Laboratory of Medical Molecular Virology of the Ministries of Education and Health, Institutes of Biomedical Sciences and the Institute of Medical Microbiology, School of Basic Medical Sciences, Fudan University , Shanghai 200032, China.

PMID: 26038513 PMCID: PMC3974338 DOI: 10.1038/emi.2014.21

Abstract

To evaluate the association between mutations in the genes gyrA/B and resistance levels to fluoroquinolones in clinical isolates of Mycobacterium tuberculosis, a total of 80 ofloxacin-resistant isolates collected in 2009 by the Shanghai Municipal Centers for Disease Control and Prevention were studied. The minimum inhibitory concentration (MIC) of ofloxacin, moxifloxacin and gatifloxacin for each isolate was determined using the microscopic observation drug susceptibility assay. Sequencing was used to identify mutations in the quinolone resistance-determining region (QRDR) of the gyrA and gyrB genes. In total, 68 isolates had mutations in gyrA, three isolates had mutations in gyrB, six isolates had mutations in both gyrA and gyrB, and three isolates had no mutations. Two common mutations in gyrA, the D94G and D94N mutations, were associated with higher-level resistance to all three fluoroquinolones than two other common mutations (A90V and D94A). Understanding the relationship between MICs and mutations in ofloxacin-resistant isolates will facilitate the optimization of the use of new-generation fluoroquinolones to treat patients with ofloxacin-resistant tuberculosis (TB).

Keywords: M. tuberculosis; MICs; fluoroquinolones; mutations

References

  1. BMC Infect Dis. 2011 Mar 29;11:78 - PubMed
  2. J Antimicrob Chemother. 2012 May;67(5):1088-93 - PubMed
  3. N Engl J Med. 2006 Oct 12;355(15):1539-50 - PubMed
  4. J Infect. 2010 Jul;61(2):150-4 - PubMed
  5. Proteins. 2010 Feb 1;78(2):492-5 - PubMed
  6. Nature. 1997 Aug 28;388(6645):903-6 - PubMed
  7. J Clin Microbiol. 1998 Apr;36(4):937-43 - PubMed
  8. Lancet Infect Dis. 2003 Jul;3(7):432-42 - PubMed
  9. J Infect Dis. 1996 Nov;174(5):1127-30 - PubMed
  10. Antimicrob Agents Chemother. 2004 Apr;48(4):1281-8 - PubMed
  11. J Antimicrob Chemother. 2012 Apr;67(4):819-31 - PubMed
  12. Int J Antimicrob Agents. 2013 Sep;42(3):232-7 - PubMed
  13. J Antimicrob Chemother. 2009 Jun;63(6):1173-8 - PubMed
  14. Eur Respir J. 2011 Sep;38(3):516-28 - PubMed
  15. PLoS One. 2012;7(6):e39754 - PubMed
  16. Antimicrob Agents Chemother. 2006 Jan;50(1):104-12 - PubMed
  17. Antimicrob Agents Chemother. 2012 Apr;56(4):1990-6 - PubMed
  18. Antimicrob Agents Chemother. 2009 Oct;53(10):4498-500 - PubMed
  19. Clin Infect Dis. 2009 Oct 1;49(7):1080-2 - PubMed
  20. PLoS One. 2010 Aug 18;5(8):e12245 - PubMed
  21. Microb Drug Resist. 2006 Spring;12(1):7-11 - PubMed
  22. FEMS Immunol Med Microbiol. 2011 Oct;63(1):1-9 - PubMed
  23. Int J Tuberc Lung Dis. 2008 Feb;12(2):128-38 - PubMed
  24. J Infect Dis. 2012 May 15;205 Suppl 2:S147-58 - PubMed

Publication Types